CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 245,450	$ 126,450
Restricted cash	0	12,413
Patient accounts receivable	301,050	313,373
Prepaid expenses	20,485	14,639
Other current assets	12,962	30,060
Total current assets	579,947	496,935
Property and equipment, net of accumulated depreciation of $101,003 and $92,422	42,000	41,845
Operating lease right of use assets	85,110	88,939
Goodwill	1,244,679	1,244,679
Intangible assets, net of accumulated amortization of $17,603 and $14,008	99,698	102,675
Other assets	87,680	85,097
Total assets	2,139,114	2,060,170
Current liabilities:
Accounts payable	32,117	28,237
Payroll and employee benefits	138,374	136,835
Accrued expenses	145,611	140,049
Termination fee paid by UnitedHealth Group	106,000	106,000
Current portion of long-term obligations	37,478	36,314
Current portion of operating lease liabilities	26,441	26,286
Total current liabilities	486,021	473,721
Long-term obligations, less current portion	344,428	361,862
Operating lease liabilities, less current portion	59,323	62,751
Deferred income tax liabilities	48,017	40,635
Other long-term obligations	886	1,418
Total liabilities	938,675	940,387
Commitments and Contingencies—Note 7
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,267,133 and 38,131,478 shares issued; 32,751,131 and 32,667,631 shares outstanding	38	38
Additional paid-in capital	809,655	787,177
Treasury stock, at cost, 5,516,002 and 5,463,847 shares of common stock	(473,466)	(468,626)
Retained earnings	811,537	747,925
Total Amedisys, Inc. stockholders’ equity	1,147,764	1,066,514
Noncontrolling interests	52,675	53,269
Total equity	1,200,439	1,119,783
Total liabilities and equity	$ 2,139,114	$ 2,060,170